BRAF V600E and V600K in Melanoma: Clinicopathologic Correlation

被引：0
|
作者：
Purgina, B. M. [1 ]
Jelic, T. [1 ]
Chiosea, S. I. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
535
引用
收藏
页码：131A / 131A
页数：1
相关论文
共 50 条
  • [21] Vemurafenib in Melanoma with BRAF V600E Mutation
    Morita, Hiroyuki
    Nagai, Ryozo
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1448 - 1448
  • [22] Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR
    Reid, Anna L.
    Freeman, James B.
    Millward, Michael
    Ziman, Melanie
    Gray, Elin S.
    CLINICAL BIOCHEMISTRY, 2015, 48 (15) : 999 - 1002
  • [23] Accuracy evaluation of a novel companion diagnostic method for BRAF V600E/V600K identification in GSK clinical trials
    O'Donnell, L.
    Sweet, W.
    Lu, X.
    Meynier, F.
    Derome, A.
    Ganee, L.
    Poyet-Gelas, F.
    Martin, A.
    Casey, M.
    Kertesz, N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S26 - S27
  • [24] Distinct gene expression, mutational profile and clinical outcomes of V600E and V600K/R BRAF-mutant metastatic melanoma (MM).
    Da Silva, Ines Esteves Domingues Pires
    Wang, Kevin Y. X.
    Wilmott, James S.
    Hoist, Jeffrey
    Park, John J.
    Quek, Camelia
    Wongchenko, Matthew
    Yan, Yibing
    Mann, Graham J.
    Carlino, Matteo S.
    Kefford, Richard
    Scolyer, Richard A.
    Yang, Jean
    Long, Georgina V.
    Rizos, Helen
    Menzies, Alexander M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] Immunohistochemical BRAF V600E Expression and Intratumor BRAF V600E Heterogeneity in Acral Melanoma: Implication in Melanoma-Specific Survival
    Ito, Takamichi
    Kaku-Ito, Yumiko
    Murata, Maho
    Furue, Kazuhisa
    Shen, Che-Hung
    Oda, Yoshinao
    Furue, Masutaka
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [26] A HRM assay for identification of low level BRAF V600E and V600K mutations using the CADMA principle in FFPE specimens
    Huebner, Claudia
    Weber, Remeny
    Lloydd, Richard
    PATHOLOGY, 2017, 49 (07) : 776 - 783
  • [27] Dabrafenib in advanced melanoma with BRAF V600E mutation
    Abraham, Jame
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (02): : 48 - 49
  • [28] Acral Lentiginous Melanomas Harbour Intratumor Heterogeneity in BRAF Exon 15, With Mutations Distinct From V600E/V600K
    Fernandes, Mariana
    Barcelos, Denise
    Comodo, Andreia Neves
    Guimaraes, Daiane Pereira
    Lopes Carapeto, Fernando Cintra
    Cardili, Leonardo
    Moraes, Lais de Sousa
    Cerutti, Janete
    Landman, Gilles
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2019, 41 (10) : 733 - 740
  • [29] Clinicopathologic and genetic characterization of invasive melanoma with BRAF V600K mutation: A study of 16 cases
    Goto, Keisuke
    Yoshikawa, Shusuke
    Takai, Toshihiro
    Tachibana, Kota
    Honma, Keiichiro
    Isei, Taiki
    Kukita, Yoji
    Oishi, Takuma
    JOURNAL OF CUTANEOUS PATHOLOGY, 2023, 50 (08) : 739 - 747
  • [30] BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Del Bufalo, Francesca
    Ceglie, Giulia
    Cacchione, Antonella
    Alessi, Iside
    Colafati, Giovanna Stefania
    Carai, Andrea
    Diomedi-Camassei, Francesca
    De Billy, Emmanuel
    Agolini, Emanuele
    Mastronuzzi, Angela
    Locatelli, Franco
    FRONTIERS IN ONCOLOGY, 2018, 8
12345